Computer score from heart ultrasound to predict risk in aortic stenosis
Tests a computer-based score for judging risk in older adults with mild aortic stenosis.
Key facts
- Who runs it
- Yale University
- Where
- Houston, New Haven, and New York, United StatesSee the 3 sites
- Trial code
- Registry title
- Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
- Status
- Enrolling by invitation
- People taking part
- 210 people, planned
- Started
- 6 May 2026
- Expected to end
- 31 Aug 2028
- Type of study
- Observational
- Treatments tested
- Transthoracic echocardiogram
- Record updated
- 8 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 65 or older with aortic sclerosis or mild aortic stenosis, a stiffening or narrowing of the heart's main valve. It tests a digital score for predicting risk.
- Age
- 65 years or older
- Sex
- All sexes can join
- Disease stage
- Aortic sclerosis without narrowing, or mild aortic stenosis, seen on a heart ultrasound (transthoracic echocardiogram) in the past 2-3 years
- Earlier treatment
- People who have had their aortic valve replaced or repaired, by catheter or surgery, cannot join.
Main reasons for not taking part
- Any echocardiogram within 24 months of the medical record review
- Implanted heart device, such as a pacemaker, defibrillator or left ventricular assist device
- Prior heart transplant or history of dementia
- Life expectancy of <1 year, or currently in hospice care
- Does not speak English, or cannot attend the study visit at the echocardiogram lab within four years of the last echocardiogram
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age 65 years or older
- Prior transthoracic echocardiogram within the past 2-3 years showing aortic sclerosis without stenosis or mild AS
Who cannot take part
- Prior history of aortic valve replacement or repair, including transcatheter and surgical AVR with either a bioprosthetic or mechanical valve
- Prior heart transplant
- Presence of implantable cardiac devices, including permanent cardiac pacer, implantable cardioverter-defibrillator, or left ventricular assist device
- History of dementia
- Opted out of research studies
- Non-English speaking
- Any echocardiogram within 24 months of medical record review
- Unable to attend study visit at echocardiogram lab within four years of most recent echocardiogram
- Documented life expectancy of <1 year or current participation in hospice services
Where in United States
- The Methodist Hospital Research InstituteHouston, United StatesEnrolling by invitation
- Yale-New Haven Health SystemNew Haven, United StatesEnrolling by invitation
- Icahn School of Medicine at Mount SinaiNew York, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study will evaluate the validity of a digital biomarker score for precision risk stratification among older adults with aortic sclerosis or mild aortic stenosis (AS) at three US health systems.
Treatments tested
- Transthoracic echocardiogram
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
- Plain-language title
- Computer score from heart ultrasound to predict risk in aortic stenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 8 May 2026